Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Jeffrey D. Dunn, PharmD, MBA
Senior Vice President,
VRx Pharmacy Services,
Salt Lake City, UT
Senior Vice President, VRx Pharmacy Services, Salt Lake City, UT
Authored Items
Helping Patients Cope with Agitation: The Role of Pharmacists and Payers
Jeffrey D. Dunn, PharmD, MBA
Faculty Perspectives: Coping with Agitation Associated with Schizophrenia and Bipolar Disorder: How Can Healthcare Professionals Help Their Patients?
Addressing the Challenges of Treating Schizophrenia and Bipolar Disorder
Jeffrey D. Dunn, PharmD, MBA
Faculty Perspectives: The Spectrum of Agitation Associated with Schizophrenia and Bipolar Disorder
Impact of Glycemic Control on Healthcare Resource Utilization and Costs of Type 2 Diabetes: Current and Future Pharmacologic Approaches to Improving Outcomes
Mary Ann Banerji, MD, FACP
,
Jeffrey D. Dunn, PharmD, MBA
,
Jeffrey A. Bourret, PharmD
September 2013, Vol 6, No 7
in
Business
Last modified: October 4, 2013